Prinz PU - Search Results

1

Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation.

Mendler AN, Hu B, Prinz PU, Kreutz M, Gottfried E, Noessner E. Mendler AN, et al. Among authors: prinz pu. Int J Cancer. 2012 Aug 1;131(3):633-40. doi: 10.1002/ijc.26410. Epub 2011 Oct 5. Int J Cancer. 2012. PMID: 21898391 Free article.

2

High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.

Prinz PU, Mendler AN, Masouris I, Durner L, Oberneder R, Noessner E. Prinz PU, et al. J Immunol. 2012 Jun 15;188(12):5990-6000. doi: 10.4049/jimmunol.1103028. Epub 2012 May 9. J Immunol. 2012. PMID: 22573804

3

NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention.

Prinz PU, Mendler AN, Brech D, Masouris I, Oberneder R, Noessner E. Prinz PU, et al. Int J Cancer. 2014 Oct 15;135(8):1832-41. doi: 10.1002/ijc.28837. Epub 2014 Mar 26. Int J Cancer. 2014. PMID: 24615391 Free article.

4

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma.

Noessner E, Brech D, Mendler AN, Masouris I, Schlenker R, Prinz PU. Noessner E, et al. Among authors: prinz pu. Oncoimmunology. 2012 Nov 1;1(8):1451-1453. doi: 10.4161/onci.21356. Oncoimmunology. 2012. PMID: 23243626 Free PMC article.

5

Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.

Figel AM, Brech D, Prinz PU, Lettenmeyer UK, Eckl J, Turqueti-Neves A, Mysliwietz J, Anz D, Rieth N, Muenchmeier N, Buchner A, Porubsky S, Siegert SI, Segerer S, Nelson PJ, Noessner E. Figel AM, et al. Among authors: prinz pu. Am J Pathol. 2011 Jul;179(1):436-51. doi: 10.1016/j.ajpath.2011.03.011. Epub 2011 May 18. Am J Pathol. 2011. PMID: 21703422 Free PMC article.

6

Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.

Eckl J, Buchner A, Prinz PU, Riesenberg R, Siegert SI, Kammerer R, Nelson PJ, Noessner E. Eckl J, et al. Among authors: prinz pu. J Mol Med (Berl). 2012 Jan;90(1):55-66. doi: 10.1007/s00109-011-0806-7. Epub 2011 Aug 26. J Mol Med (Berl). 2012. PMID: 21870102

7

WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.

Fløisand Y, Remberger M, Bigalke I, Josefsen D, Vålerhaugen H, Inderberg EM, Olaussen RW, Gjertsen BT, Goedkoop R, Geiger C, Prinz PU, Schnorfeil FM, Pinkernell K, Schendel DJ, Kvalheim G. Fløisand Y, et al. Among authors: prinz pu. Leukemia. 2023 Sep;37(9):1842-1849. doi: 10.1038/s41375-023-01980-3. Epub 2023 Jul 28. Leukemia. 2023. PMID: 37507426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page